News

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I). This is an ASCO Meeting Abstract ...
In cases where care refusals were described, we were not able to clarify whether the physician was describing the use of legitimate reasons to turn away patients (for example, the physician ...
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In The Lancet, Ashish ...
ORLANDO -- Even type 2 diabetes patients with impaired renal function saw improvements in weight and glycemic control with a dual SGLT1/2 inhibitor, according to a meta-analysis. Among nearly ...
A Carlow Councillor has called for designated parking spaces for ambulances outside all medical centres, doctor’s surgeries and pharmacies across the county. At the local authority’s monthly meeting, ...
COLUMBUS, Ohio (AP) — Ohio State women’s basketball coach Kevin McGuff, the Big Ten's 2024 coach of the year, was charged with operating a vehicle while impaired last week, police said.
Herceptin’s beacon is a protein called HER2, and it works best for people whose tumors are spurred to grow by the HER2 signal—yet that’s only about one fifth of breast cancer patients.
From left are Toyota Mobility Solutions (TMS) Chief Operating Officer Ryo Yokoyama, TMS President Ma. Christina Fe Arevalo, JoyRide Philippines President Neil Sherwin Yu, and JoyRide Philippines ...
Patients with mild AS demonstrated a greater likelihood of impaired MFR compared with patients with no AS, with an odds ratio (OR) of 2.54 (95% CI, 1.44–4.51). Likewise, patients with moderate AS had ...
Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug (casdozo, SRF388) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients ...
Hay fever sufferers were today warned against buying unlicensed jabs from private clinics over terrifying health risks that could leave patients blind. The powerful prescription-only drug Kenalog ...